Relay Therapeutics Inc
NASDAQ:RLAY
Balance Sheet
Balance Sheet Decomposition
Relay Therapeutics Inc
Current Assets | 770.1m |
Cash & Short-Term Investments | 749.6m |
Other Current Assets | 20.5m |
Non-Current Assets | 71.3m |
PP&E | 66.3m |
Intangibles | 2.3m |
Other Non-Current Assets | 2.7m |
Current Liabilities | 37.1m |
Accounts Payable | 8m |
Accrued Liabilities | 27.5m |
Other Current Liabilities | 1.7m |
Non-Current Liabilities | 58.5m |
Other Non-Current Liabilities | 58.5m |
Balance Sheet
Relay Therapeutics Inc
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
422
|
42
|
448
|
280
|
152
|
144
|
|
Cash Equivalents |
422
|
42
|
448
|
280
|
152
|
144
|
|
Short-Term Investments |
0
|
314
|
230
|
678
|
847
|
606
|
|
Total Receivables |
0
|
0
|
83
|
5
|
5
|
0
|
|
Accounts Receivables |
0
|
0
|
83
|
5
|
5
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
3
|
5
|
9
|
13
|
15
|
20
|
|
Total Current Assets |
424
|
361
|
770
|
976
|
1 020
|
770
|
|
PP&E Net |
4
|
32
|
29
|
27
|
75
|
69
|
|
PP&E Gross |
4
|
32
|
29
|
27
|
75
|
69
|
|
Accumulated Depreciation |
5
|
7
|
11
|
14
|
18
|
24
|
|
Intangible Assets |
0
|
0
|
0
|
2
|
2
|
2
|
|
Other Long-Term Assets |
1
|
1
|
1
|
3
|
3
|
3
|
|
Total Assets |
429
N/A
|
393
-8%
|
800
+103%
|
1 008
+26%
|
1 100
+9%
|
844
-23%
|
|
Liabilities | |||||||
Accounts Payable |
5
|
7
|
6
|
8
|
11
|
9
|
|
Accrued Liabilities |
2
|
5
|
7
|
15
|
25
|
19
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
1
|
28
|
2
|
|
Total Current Liabilities |
7
|
12
|
14
|
24
|
64
|
30
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
1
|
24
|
23
|
86
|
86
|
62
|
|
Total Liabilities |
7
N/A
|
36
+382%
|
37
+2%
|
111
+203%
|
150
+35%
|
92
-39%
|
|
Equity | |||||||
Common Stock |
532
|
538
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
114
|
190
|
404
|
768
|
1 059
|
1 401
|
|
Additional Paid In Capital |
3
|
9
|
1 167
|
1 667
|
2 019
|
2 153
|
|
Other Equity |
0
|
0
|
0
|
1
|
10
|
0
|
|
Total Equity |
421
N/A
|
357
-15%
|
763
+114%
|
898
+18%
|
950
+6%
|
752
-21%
|
|
Total Liabilities & Equity |
429
N/A
|
393
-8%
|
800
+103%
|
1 008
+26%
|
1 100
+9%
|
844
-23%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
87
|
87
|
90
|
108
|
121
|
127
|